Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38123

HNRNPA0 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

HNRNPA0 Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population in HEK293T cells targeting the HNRNPA0 gene. HNRNPA0 encodes an AU-rich element-binding protein that is phosphorylated by MAPKAPK2 downstream of p38 MAPK signaling, modulating the stability of target mRNAs such as TNF-?? and COX-2. This model enables investigation of post-transcriptional gene regulation and ARE-mediated decay in a widely used human epithelial cell line. Applications include RNA immunoprecipitation, mRNA stability assays, and functional genomics studies, with the polyclonal format minimizing clonal artifacts. For detailed product information, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    HNRNPA0

    Gene Identifier

    NCBI Gene ID 10949

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The HNRNPA0 Knockout HEK293T Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HEK293T human embryonic kidney cell line, engineered to disrupt the HNRNPA0 gene. HNRNPA0 encodes an AU-rich element (ARE)-binding protein that post-transcriptionally regulates mRNA stability and translation. This polyclonal knockout pool offers a heterogeneous population with disrupted HNRNPA0 expression, providing a robust loss-of-function model without clonal selection artifacts. It serves as a valuable tool for dissecting the role of HNRNPA0 in mRNA metabolism and signaling.

The parental HEK293T cell line, derived from human embryonic kidney epithelium, stably expresses the SV40 large T antigen, enabling episomal replication of plasmids with the SV40 origin. This feature supports high-level protein expression and viral propagation, making HEK293T a preferred host for functional genomics and CRISPR-based knockout generation. Its well-characterized growth and epithelial morphology facilitate diverse downstream analyses, including high-throughput screening and imaging.

HNRNPA0 mediates ARE-directed mRNA decay and translational control by binding AU-rich elements in 3?? UTRs of targets like TNF-??, COX-2, and IL-6 mRNAs. Upon stimulation by cytokines or stress, p38 MAPK phosphorylates MAPKAPK2, which then phosphorylates HNRNPA0, altering its RNA-binding affinity and subcellular localization. This modulates the stability of ARE-containing transcripts, regulating inflammatory and stress responses. HNRNPA0 also interacts with HuR, AUF1, and TIA-1, integrating signals into post-transcriptional regulatory networks.

In the HEK293T background, HNRNPA0 knockout enables dissection of ARE-mediated regulatory mechanisms in a genetically tractable, well-characterized cell model. The polyclonal nature of the knockout pool recapitulates population-level heterogeneity, minimizing clonal bias while allowing robust assessment of gene function. Researchers can investigate how loss of HNRNPA0 affects basal and stimulus-induced expression of inflammatory mediators, or explore its role in splicing and nuclear export. The combination of SV40 large T antigen expression and HNRNPA0 disruption creates a versatile platform for studying RNA-protein interactions and signal-dependent mRNA turnover in epithelial cells.

This knockout model is suited for studying post-transcriptional gene regulation, ARE-mediated mRNA decay, and p38 MAPK signaling. Applications include western blotting, RT-qPCR for target mRNAs, RNA immunoprecipitation, actinomycin D chase assays, ARE-luciferase reporters, and cytokine ELISA. The cells also support RNA-seq for transcriptome-wide analyses. For further information or to request a quote, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)